Breast Encapsulation Treatment with Shockwave

Encountering capsular fibrosis, often known as “encapsulation,” after breast augmentation surgery remains one of the most prevalent long-term complications.  This condition which typically appears within 2 years of surgery, involves the development of scar tissue around the implant, leading to hardening and discomfort in the breast tissue.

Traditionally, surgical intervention has been the go-to treatment.  However, a groundbreaking alternative has emerged—shockwave therapy.

At Las Vegas Aesthetics, we utilize Extracorporeal shock wave therapy (ESWT), better known as Focused “Shockwave therapy,” a quick, non-invasive, painless treatment utilizing sound waves, renowned for its success in addressing erectile dysfunction and urinary incontinence.

This technology, initially recognized for its efficacy in treating areas such as skin tightening, cellulite reduction, and body contouring, has shown significant promise in treating capsular contracture and avoiding potential revision surgery.  The shockwave’s ability to inhibit inflammatory processes and reveal antibacterial properties is noteworthy.

In studies, it has displayed the capacity to slow down capsular development, potentially stemming from “subclinical” or unnoticed bacterial contamination on the implant surface, thought to be the precursor triggering an inflammatory reaction, which leads to the fibrosis.

Post-surgical bleeding or fluid collections (seroma) possibly due to early drain removal can also contribute to future capsular development and should be prophylactically treated with ESWT as early as possible.

Focused Shockwave has been used on leading breast implant brands at maximum settings, assuring their safety without any harm.

Encouraged by these outcomes, patients with the slightest risk of developing capsular contracture or patients exhibiting even the earliest of signs, can benefit greatly with a preventative treatment series.